AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Venlafaxine Hydrochloride Equivalent To Venlafaxine

9 registrations across 1 African market— 7 active

Markets with Venlafaxine Hydrochloride Equivalent To Venlafaxine

Recent registrations

Brand / ProductMarketHolderStatusExpires
ODIVEN XR 75🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveSept 2029
ODIVEN XR 150🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveSept 2029
ODIVEN XR 37,5🇿🇦South AfricaZydus Healthcare (Pty) LtdactiveSept 2029
VENLOR XR 37,5 mg TABLET🇿🇦South AfricaCipla Medpro (Pty) LtdactiveAug 2028
VENLOR XR 75 mg TABLET🇿🇦South AfricaCipla Medpro (Pty) LtdactiveAug 2028
VENLOR XR 150 mg TABLET🇿🇦South AfricaCipla Medpro (Pty) LtdactiveAug 2028
VENLOR XR 225 mg TABLET🇿🇦South AfricaCipla Medpro (Pty) LtdunknownAug 2028
VENLOR XR 300 mg TABLET🇿🇦South AfricaCipla Medpro (Pty) LtdunknownAug 2028
VENLOR 37,5🇿🇦South AfricaCipla Medpro (Pty) LtdactiveJan 1900

Venlafaxine Hydrochloride Equivalent To Venlafaxine in Africa — Regulatory Overview

Venlafaxine Hydrochloride Equivalent To Venlafaxine is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 7 (78%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.